Amani Therapeutics, Inc.

CIK 2099941 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Amani Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Dec 10, 2025D0002099941-25-000001